tiprankstipranks
Trending News
More News >
Adaptimmune price target lowered to $1.75 from $3 at Guggenheim
PremiumThe FlyAdaptimmune price target lowered to $1.75 from $3 at Guggenheim
1M ago
Adaptimmune’s Earnings Call: TECELRA Success and Future Outlook
Premium
Company Announcements
Adaptimmune’s Earnings Call: TECELRA Success and Future Outlook
2M ago
Adaptimmune price target lowered to $1.40 from $3.15 at Scotiabank
Premium
The Fly
Adaptimmune price target lowered to $1.40 from $3.15 at Scotiabank
2M ago
Adaptimmune Therapeutics Announces Key Leadership Changes
PremiumCompany AnnouncementsAdaptimmune Therapeutics Announces Key Leadership Changes
5M ago
Adaptimmune price target lowered to $1.50 from $3 at Mizuho
Premium
The Fly
Adaptimmune price target lowered to $1.50 from $3 at Mizuho
5M ago
Adaptimmune price target lowered to $3 from $4 at Guggenheim
Premium
The Fly
Adaptimmune price target lowered to $3 from $4 at Guggenheim
6M ago
Is ADAP a Buy, Before Earnings?
PremiumPre-EarningsIs ADAP a Buy, Before Earnings?
6M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
9M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100